Xcout Intel
Biome ATS competitors & alternatives
The 12 closest competitors and alternatives to Biome ATS among biotechnology companies — ranked by similarity to what Biome ATS actually does, not by market-cap band.
Subscribe to see Biome ATS’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About Biome ATS
BiomeBank develops and commercializes microbiome therapeutics designed to restore gut ecological complexity and treat human diseases. The company offers regulated donor-derived therapies, such as BIOMICTRA for recurrent Clostridioides difficile infections, and is advancing a pipeline of next-generation co-cultured microbial products for conditions spanning immunology, metabolism, and oncology. It serves medical practitioners and patients by providing clinically informed gut health treatments.
Biome ATS at a glance
Biome ATS is a biotechnology company headquartered in South Korea. Xcout tracks 18 named people at Biome ATS, including Justin Green (Chief Financial Officer).
Biome ATS leadership
- Justin GreenChief Financial Officer
- Dr Sam CostelloChief Executive Officer & Co-founder
- Prof Sam ForsterChief Scientific Officer // Co-Founder
- Prof Rob BryantVP Clinical Translation and Co-founder
- Dr Emily TuckerHead of Medical Affairs // Co-Founder
- Andrew RobertsonHead of R&D
12 more named people on record for Biome ATS, with roles, board committees and tenure — see the full roster →
Top 12 Biome ATS competitors
Ranked by semantic similarity — how close each company is to Biome ATS by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Similar biotechnology company
The OpenBiome Foundation expands patient access to microbiome therapies and drives scientific discovery to advance human health. The organization provides resources, strategic collaborations, and investments to equip clinicians, researchers, and healthcare systems with tools for microbiome-directed treatments.
Similar biotechnology company
Arranta Bio is a biotechnology contract development and manufacturing organization (CDMO) focused on microbiome-based therapeutics, including live biotherapeutic products. It serves biopharmaceutical companies with process development, analytical, and manufacturing services for these products.
Similar biotechnology company
Federation Bio is a U.S. biotechnology company developing live biotherapeutic products based on defined microbial communities to treat diseases. Its work has focused on microbiome-based therapies for metabolic and other serious disorders, serving patients with conditions that may benefit from engineered microbial consortia.
Biotech
Seres Therapeutics, Inc. is a pioneering microbiome therapeutics firm dedicated to engineering bacterial consortia that modulate host cells and tissues to combat various diseases. Their flagship therapeutic, SER-109, an oral microbiome treatment, has successfully concluded Phase III clinical trials for the management of Clostridioides difficile infection (CDI). The company's pipeline further encompasses SER-155, a synthetically cultured bacterial formulation currently undergoing Phase Ib evaluation. This candidate aims to mitigate the risk of gastrointestinal and bloodstream infections, alongside graft-versus-host disease, in vulnerable patients undergoing allogeneic hematopoietic stem cell or solid organ transplantation. Additionally, Seres Therapeutics is advancing SER-287 and SER-301, both in Phase Ib for ulcerative colitis, as well as SER-401, which targets metastatic melanoma, and SER-262, also directed at Clostridioides difficile infection. Seres maintains strategic alliances through licensing and collaboration agreements with entities such as Nestec Ltd. and Memorial Sloan Kettering Cancer Center. Established in 2010, the company previously operated as Seres Health, Inc. before adopting its current name in May 2015, and it maintains its principal offices in Cambridge, Massachusetts.
Similar biotechnology company
Notitia Biotechnologies Co develops microbiome-focused products and programs aimed at promoting and restoring the Foundation Guild of gut bacteria for wellness and clinical applications. The company serves patients and the general public seeking to improve their gut health and overall healthspan.
Biotech
ClostraBio, Inc. is a Chicago-based biotechnology research company pioneering microbiome-based solutions, next-generation probiotics for gut health, and advanced metabolite delivery solutions for inflammatory bowel disease.
Similar biotechnology company
Bloom Labs Bio Inc. specializes in the development and manufacturing of biologics, biosimilars, recombinant proteins, monoclonal antibodies, prebiotics, and probiotics. Utilizing modern biotechnology platforms and advanced infrastructure, the company serves the pharmaceutical and life sciences sectors with therapeutic and health and wellness solutions.
Life Sciences
BMI OrganBank is a medical device and biotechnology company developing next-generation organ and tissue transplant solutions.
Life Sciences
Vedanta Biosciences, Inc. is headquartered in Cambridge, Massachusetts, and develops groundbreaking microbiome-derived immunotherapies and therapeutics to improve patient lives.
Biotech
MaaT Pharma is a clinical-stage biotechnology company that develops microbiome-based therapeutics to improve treatment outcomes and survival rates for cancer patients. The company focuses on restoring microbiome function to address life-threatening diseases using a full ecosystem approach and AI-powered drug development.
Similar biotechnology company
Exeliom Biosciences is a clinical-stage biopharmaceutical company headquartered in France that develops novel therapeutic approaches harnessing microbiome-host interactions.
Life Sciences
The Akkermansia Company is a privately held life science company based in Mont-Saint-Guibert, Belgium. The company conducts clinical studies and commercializes health products based on pasteurized Akkermansia bacteria.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of Biome ATS and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for Biome ATSand every competitor above — in one live dashboard.
Subscribe to Xcout Intel →